Code | 7421E | ||||||||||
MA number | EU/1/24/1841/009 | ||||||||||
Product Form: | tbl flm 56x4 mg (fľ.HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Janssen - Cilag International N.V., Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.08.2024 |
Validity: | 22.08.2029 |
Safety feature | Yes |
Data update: | 06.09.2024 |